title: New insights into tumor dormancy: Targeting DNA repair pathways.
abstract: Over the past few decades, major strides have advanced the techniques for early detection and treatment of cancer. However, metastatic tumor growth still accounts for the majority of cancer-related deaths worldwide. In fact, breast cancers are notorious for relapsing years or decades after the initial clinical treatment, and this relapse can vary according to the type of breast cancer. In estrogen receptor-positive breast cancers, late tumor relapses frequently occur whereas relapses in estrogen receptor-negative cancers or triple negative tumors arise early resulting in a higher mortality risk. One of the main causes of metastasis is tumor dormancy in which cancer cells remain concealed, asymptomatic, and untraceable over a prolonged period of time. Under certain conditions, dormant cells can re-enter into the cell cycle and resume proliferation leading to recurrence. However, the molecular and cellular regulators underlying this transition remain poorly understood. To date, three mechanisms have been identified to trigger tumor dormancy including cellular, angiogenic, and immunologic dormancies. In addition, recent studies have suggested that DNA repair mechanisms may contribute to the survival of dormant cancer cells. In this article, we summarize the recent experimental and clinical evidence governing cancer dormancy. In addition, we will discuss the role of DNA repair mechanisms in promoting the survival of dormant cells. This information provides mechanistic insight to explain why recurrence occurs, and strategies that may enhance therapeutic approaches to prevent disease recurrence.
authors.affiliation: Elizabeth B Evans, Shiaw-Yih Lin, Department of Systems Biology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
authors.forename: Elizabeth B
authors.initials: EB
authors.lastname: Evans
authors.affiliation: Elizabeth B Evans, Shiaw-Yih Lin, Department of Systems Biology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.
authors.forename: Shiaw-Yih
authors.initials: SY
authors.lastname: Lin
keywords: DNA repair; Homologous recombination; Non-homologous end joining; Quiescence; Tumor dormancy